26th Neuropharmacology Conference 2016
10 – 11 November 2016 | San Diego, USA
Glutamate is the major excitatory neurotransmitter in the central nervous system where its actions are mediated largely via three classes of ionotropic glutamate receptors (iGluRs) – AMPA, NMDA and kainate. These receptors are involved in numerous physiological functions and are the targets of drugs used in the treatment of Alzheimer’s disease, epilepsy and pain.
The 26th Neuropharmacology Conference will provide an overview of the field with a particular focus on recent advances in iGluR structure, the design of new ligands and the role of iGluRs in synaptic plasticity.
There will be a major emphasis on how the study of iGluRs is leading to considerable insights into the aetiology of major disorders, such as depression, schizophrenia and autism, and will evaluate the potential of targeting iGluRs for new therapies.
- Ionotropic glutamate receptors
- Synaptic plasticity and memory
- Homeostatic plasticity
- Physiology and signaling
- Neurological and psychiatric disorders
- Novel therapeutic approaches and potential applications